Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for obstructive sleep apnea in overweight hypogonadal men
ACTRN12612000536864Phase 3Withdrawn
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Jul 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Celebrex with Placebo (2 arms). Primary endpoints: Serial reproductive hormone profiles, Insulin sensitivity and 1 more. Planned start Jul 2012; status: withdrawn.
02
Drugs
celecoxib
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12612000536864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000536864.